Operationalisation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 trials in a low and lower-middle income critical care learning health system.

The Randomized Embedded Multifactorial Adaptive Platform (REMAP-CAP) adapted for COVID-19) trial is a global adaptive platform trial of hospitalised patients with COVID-19. We describe implementation in three countries under the umbrella of the Wellcome supported Low and Middle Income Country (LMIC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Aryal, Diptesh, Beane, Abi, Dondorp, Arjen M., Green, Cameron, Haniffa, Rashan, Hashmi, Madiha, Jayakumar, Devachandran, Marshall, John C., McArthur, Colin J., Murthy, Srinivas, Webb, Steven A., Acharya, Subhash P., Ishani, Pramodya G. P., Jawad, Issrah, Khanal, Sushil, Koirala, Kanchan, Luitel, Subekshya, Pabasara, Upulee, Paneru, Hem Raj, Kumar, Ashok, Patel, Shoaib Siddiq, Ramakrishnan, Nagarajan, Salahuddin, Nawal, Shaikh, Mohiuddin, Tolppa, Timo, Udayanga, Ishara, Umrani, Zulfiqar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Open Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883321/
https://www.ncbi.nlm.nih.gov/pubmed/33604455
http://dx.doi.org/10.12688/wellcomeopenres.16486.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883321/
https://www.ncbi.nlm.nih.gov/pubmed/33604455
http://dx.doi.org/10.12688/wellcomeopenres.16486.1

Ejemplares similares